All Health Partnerships, Great and Small: Comparing Mandated With Emergent Health Partnerships; Comment on “Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda”
Authors
Abstract:
The plurality of healthcare providers and funders in low- and middle-income countries (LMICs) has given rise to an era in which health partnerships are becoming the norm in international development. Whether mandated or emergent, three common drivers are essential for ensuring successful health partnerships: trust; a diverse and inclusive network; and a clear governance structure. Mandated and emergent health partnerships operate as very different models and at different scales. However, there is potential for sharing and learning between these types of partnerships. Emergent health partnerships, especially as they scale up, may learn from mandated partnerships about establishing clear governance mandates for larger and more complex partnerships. By combining social network analysis, which can detect key actors and stakeholders that could add value to existing emergent partnerships, with Brinkerhoff’s comprehensive framework for partnership evaluation, we can identify a set of tools that could be used to evaluate the effectiveness and sustainability of emergent health partnerships.
similar resources
Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
Background Global health partnerships have grown rapidly in number and scope, yet there has been less emphasis on their evaluation. Gavi, the Vaccine Alliance, is one such public-private partnership; in Gavi-eligible countries partnerships are dynamic networks of immunization actors who work together to support all stages and aspects of Gavi support. This paper describes a conceptual framework ...
full textevaluating global health partnerships: a case study of a gavi hpv vaccine application process in uganda
background global health partnerships have grown rapidly in number and scope, yet there has been less emphasis on their evaluation. gavi, the vaccine alliance, is one such public-private partnership; in gavi-eligible countries partnerships are dynamic networks of immunization actors who work together to support all stages and aspects of gavi support. this paper describes a conceptual framework ...
full textEvaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
BACKGROUND Global health partnerships have grown rapidly in number and scope, yet there has been less emphasis on their evaluation. Gavi, the Vaccine Alliance, is one such public-private partnership; in Gavi-eligible countries partnerships are dynamic networks of immunization actors who work together to support all stages and aspects of Gavi support. This paper describes a conceptual framework ...
full textAll Health Partnerships, Great and Small: Comparing Mandated With Emergent Health Partnerships
The plurality of healthcare providers and funders in lowand middle-income countries (LMICs) has given rise to an era in which health partnerships are becoming the norm in international development. Whether mandated or emergent, three common drivers are essential for ensuring successful health partnerships: trust; a diverse and inclusive network; and a clear governance structure. Mandated and em...
full textPassed the Age of Puberty: Organizational Networks as a Way to Get Things Done in the Health Field; Comment on “Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda”
In this commentary I will demonstrate that the case study of Uganda’s Human papilloma virus (HPV) vaccine application partnership provides an excellent example of widening our lens by evaluating the successful HP vaccine coverage from a network-centric perspective. That implies that the organizational network is seen as the locus of production and that network theories become indispensable to a...
full textGlobal partnerships for health.
As a reflexion on Dr Brundtland's speech, I would like to stress the important role global partnerships can play in the struggle for equitable health improvement. Dr Brundtland's focus, reasonably, is on infectious diseases with an emphasis on HIV/AIDS and SARS. She puts much emphasis on the undoubted successes in 2003 in controlling SARS, but less emphasis on our shamefully slow response to HI...
full textMy Resources
Journal title
volume 7 issue 1
pages 89- 91
publication date 2018-01-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023